“…It highlights the importance of adequate patient education, involvement of family members, pre-specified follow-up schedules, involving a local pharmacist if possible, use of technical aids (medication boxes, phone apps, reminder systems) and electronic monitoring if poor adherence is suspected. EHRA also suggests that all AF patients should receive individualized information, specific to their needs, condition and treatment, and repeated over time [19,34,36]. Moreover, HCPs should also be continuously educated, especially in rapid evolving fields and related new therapies to avoid conflicting information.…”